A detailed history of Mml Investors Services, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 22,313 shares of CADL stock, worth $182,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,313
Previous 73,376 69.59%
Holding current value
$182,520
Previous $455,000 65.93%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$5.02 - $7.76 $256,336 - $396,248
-51,063 Reduced 69.59%
22,313 $155,000
Q2 2024

Aug 14, 2024

BUY
$1.68 - $14.0 $123,271 - $1.03 Million
73,376 New
73,376 $455,000

Others Institutions Holding CADL

About Candel Therapeutics, Inc.


  • Ticker CADL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,891,900
  • Market Cap $236M
  • Description
  • Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...
More about CADL
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.